Takara Total Current Assets from 2010 to 2026
| TF2 Stock | EUR 6.05 0.05 0.82% |
Total Current Assets | First Reported 2016-12-31 | Previous Quarter 57.7 B | Current Value 44 B | Quarterly Volatility 14.9 B |
Check Takara Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takara Bio's main balance sheet or income statement drivers, such as Interest Expense of 24.1 M, Selling General Administrative of 601.1 M or Total Revenue of 45.1 B, as well as many indicators such as . Takara financial statements analysis is a perfect complement when working with Takara Bio Valuation or Volatility modules.
Takara | Total Current Assets |
The Total Current Assets trend for Takara Bio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Takara Bio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Takara Bio's Total Current Assets Growth Pattern
Below is the plot of the Total Current Assets of Takara Bio over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Takara Bio's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Takara Bio's overall financial position and show how it may be relating to other accounts over time.
| Total Current Assets | 10 Years Trend |
|
Total Current Assets |
| Timeline |
Takara Total Current Assets Regression Statistics
| Arithmetic Mean | 49,062,134,804 | |
| Geometric Mean | 47,589,753,741 | |
| Coefficient Of Variation | 26.50 | |
| Mean Deviation | 10,834,158,593 | |
| Median | 42,158,000,000 | |
| Standard Deviation | 13,000,183,360 | |
| Sample Variance | 169004767.4T | |
| Range | 42.5B | |
| R-Value | 0.69 | |
| Mean Square Error | 94506463.9T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | 1,775,707,067 | |
| Total Sum of Squares | 2704076278.2T |
Takara Total Current Assets History
About Takara Bio Financial Statements
Takara Bio stakeholders use historical fundamental indicators, such as Takara Bio's Total Current Assets, to determine how well the company is positioned to perform in the future. Although Takara Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Takara Bio's assets and liabilities are reflected in the revenues and expenses on Takara Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Takara Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Assets | 66.3 B | 53.9 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Takara Stock
Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.